EPZM
$4.39
Epizyme
($.04)
(.90%)
EPZM
Earnings Whisper ®
N/A
3rd Quarter September 2021
Consensus:  ($0.47)
Revenue:  $12.18 Mil
Friday
Nov 5
7:30 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when EPZM reports earnings?
Beat
Meet
Miss

Where is EPZM's stock price going from here?
Up
Flat
Down
Stock chart of EPZM
Analysts
Summary of analysts' recommendations for EPZM
Score
Grade
Pivots
Resistance
$4.64
$4.58
$4.51

$4.45

Support
$4.38
$4.32
$4.25
Tweet
Growth
Description
Epizyme, Inc. is a biopharmaceutical company. It engages in the discovery, development, planning, and commercialization of therapeutics for cancers. Epizyme, Inc. is headquartered in Cambridge, Massachusetts.
Peers
Vertex PharmaceuticalsUltragenyx PharmaceuticalRegeneron PharmaceuticalsBioMarin PharmaceuticalBristol-Myers SquibbInterCeptMerck & Co.Eli LillyZoetisPfizer